Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $97.6, a high estimate of $103.00, and a low estimate of $93.00. This upward trend ...

Globus Medical (NYSE:GMED – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Several other equities analysts ...

Globus Medical Inc. (NYSE:GMED), a leading medical ... Curious if GMED is one of these AI-selected gems? Check out our ProPicks platform to find out and take your investment strategy to the ...

Currently, Globus Medical is a Zacks Rank #3 (Hold ... the underlying stock does not move as much as originally expected. Check out the simple yet high-powered approach that Zacks Executive ...

Before you invest in Globus Medical, Inc. (GMED), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

Globus Medical GMED has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.81%. Currently, Globus Medical has a market ...

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning. Several other research analysts ...